Hillstream BioPharma HILS Stock Price is consolidated and ready for a run? Urgent REPORT
HILS Stock Price has been trying to recover since it’s February high of $4.
Wondering why this stock is having such a hard time and if it can break the overall trend?
Before we do, remember to stop what you are doing and 👇 Sign up for our newsletter to get the latest breakout stocks and trending stocks!
[thrive_leads id=’14274′]
Before we get started, I wanted to introduce myself to you. Hi 🙋♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.
I’m now helping traders find breakout stocks. My claim to fame is the expert at finding trending stocks.
What do I mean by big winners?
Stocks that move more than 100% in a month! HILS Stock Price could?
Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!
The article is HERE where I shine a spotlight on trending stocks and breakout stocks!
Now, let’s go over some of the basic information on this stock before we get in the technical analysis
Hillstream BioPharma Company Information
Company Name: Hillstream BioPharma Inc
Ticker: HILS
Exchange: NASDAQ
Website: https://hillstreambio.com/
Hillstream BioPharma Company Summary:
Hillstream BioPharma, Inc. is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death (IMCD) for drug resistant and devastating cancers.
It also develops the Trident Artificial Intelligence (TAI) precision medicine platform which is used to identify biomarkers in its clinical programs to target a specific patient segment. The company was founded on March 28, 2017 and is headquartered in Bridgewater, NJ.
HILS stock price is due to News?
Mar 02, 2022 (GLOBE NEWSWIRE via COMTEX) — BRIDGEWATER, NJ, March 02, 2022 (GLOBE NEWSWIRE) — Hillstream BioPharma, Inc. (NASDAQ: HILS) (“Hillstream” or the “Company”), a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers, provided a webcast replay of the Company’s R&D Day held on February 24, 2022.
HILS 5 Day Chart
HILS Stock Price Technical Analysis:
I like this stock a lot from the technical side. There is an upside of $4 and that is 100% gain. I believe there will be some consolidation and a pullback then a run. So be patient and timing is everything.
This is Alex, reminding all the traders out there to leave your emotions at the door and never, ever, try to catch a falling knife. I strive to find breakout stock alerts and deliver them before the market finds out. I sure hope you enjoyed this article, if you would like to receive more exclusive content from me 👇 sign up for our newsletter below. 👇
[thrive_leads id=’14274′]